Molecules · 2018 · 17 citations · 21 references
PharmacyMedicinal ChemistryMicrobiologyDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryAntibacterial AgentsAntibacterial PharmacologyAntimicrobial Susceptibility TestingAmino Acid DerivativesAmino Acid EstersAntibacterial Drug DevelopmentAntibiotic DiscoveryAntimicrobial Drug DevelopmentNovel Antibacterial AgentsNovel Antibacterial Drug DiscoverySpectroscopic Characterization
Several new sulfamidocarbonyloxyphosphonates were prepared in two steps, namely carbamoylation and sulfamoylation, by using chlorosulfonyl isocyanate (CSI), α-hydroxyphosphonates, and various amino derivatives and related (primary or secondary amines, β-amino esters, and oxazolidin-2-ones). All structures were confirmed by 1H, 13C, and 31P NMR spectroscopy, IR spectroscopy, and mass spectroscopy, as well as elemental analysis. Eight compounds were evaluated for their in vitro antibacterial activity against four reference bacteria including Gram-positive Staphylococcus aureus (ATCC 25923), and Gram-negative Escherichia coli (ATCC 25922), Klebsiella pneumonia (ATCC 700603), Pseudomonas aeruginosa (ATCC 27853), in addition to three clinical strains of each studied bacterial species. Compounds 1a–7a and 1b showed significant antibacterial activity compared to sulfamethoxazole/trimethoprim, the reference drug used in this study.
21
Sulfonamide resistance: mechanisms and trends
Ola Sköld · Drug Resistance Updates · 2000 · 636 citations
Francesco Abbate, Angela Casini, Takashi Owa et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 260 citations · Full text
Claudiu T. Supuran, Angela Casini, Antonio Mastrolorenzo et al. · Mini-Reviews in Medicinal Chemistry · 2004 · 162 citations
Medicine, Oncology, Pharmacology +10
Nigel A. Swain, D. V. Batchelor, Serge Beaudoin et al. · Journal of Medicinal Chemistry · 2017 · 83 citations · Full text